⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
DRREDDY - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.4
| Stock Code | DRREDDY | Market Cap | 1,06,019 Cr. | Current Price | 1,271 ₹ | High / Low | 1,380 ₹ |
| Stock P/E | 22.8 | Book Value | 378 ₹ | Dividend Yield | 0.63 % | ROCE | 25.8 % |
| ROE | 20.3 % | Face Value | 1.00 ₹ | DMA 50 | 1,268 ₹ | DMA 200 | 1,257 ₹ |
| Chg in FII Hold | -1.20 % | Chg in DII Hold | 0.28 % | PAT Qtr | 90.6 Cr. | PAT Prev Qtr | 387 Cr. |
| RSI | 49.3 | MACD | 14.0 | Volume | 10,46,223 | Avg Vol 1Wk | 23,82,872 |
| Low price | 1,121 ₹ | High price | 1,380 ₹ | PEG Ratio | 0.47 | Debt to equity | 0.13 |
| 52w Index | 57.9 % | Qtr Profit Var | -89.3 % | EPS | 55.6 ₹ | Industry PE | 30.9 |
📊 DRREDDY shows moderate potential for intraday trading. The stock is trading close to both DMA 50 and DMA 200, providing near-term support. RSI at 49.3 indicates neutral momentum, while MACD is positive. However, quarterly profit dropped sharply, and volume is below the 1-week average, suggesting limited intraday conviction.
- 💰 Optimal Buy Price: Around 1,265 ₹ (near DMA 50/200 support)
- 📈 Profit-Taking Exit Levels: 1,285 ₹ – 1,300 ₹ (short-term resistance)
- 📉 Stop-Loss / Loss Protection: 1,250 ₹ (below DMA 200)
- ⏱️ If Already Holding: Exit if price fails to sustain above 1,280 ₹ or if volume weakens further while RSI trends downward.
Positive
- Strong ROCE (25.8%) and ROE (20.3%) indicate efficient capital use
- Dividend yield of 0.63% provides shareholder return
- PEG ratio at 0.47 suggests reasonable valuation compared to growth
- EPS of 55.6 ₹ reflects solid earnings base
Limitation
- PAT dropped sharply from 387 Cr. to 90.6 Cr. (-89.3%)
- Volume significantly below 1-week average, limiting intraday momentum
- FII holdings decreased (-1.20%), showing reduced foreign confidence
Company Negative News
- Quarterly profit decline of -89.3% raises concerns
- FII holdings reduced, indicating weaker foreign investor sentiment
Company Positive News
- DII holdings increased (+0.28%), showing domestic institutional support
- Stock trading near DMA support levels, providing technical cushion
- Strong fundamentals with high ROCE and ROE
Industry
- Pharmaceutical industry P/E at 30.9, slightly higher than DRREDDY’s 22.8, suggesting relative undervaluation
- Global demand for pharma exports remains supportive
Conclusion
⚖️ DRREDDY is a moderately good candidate for intraday trading with strong fundamentals but weak recent earnings. Neutral RSI and positive MACD provide some momentum, but low volume and profit decline limit upside potential. Traders may consider entries near 1,265 ₹ with tight stop-losses and exit around 1,285–1,300 ₹. If already holding, monitor closely and exit if price weakens below 1,250 ₹.